Related Experiment Video
Updated: Jan 15, 2026
09:12
Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
Published on: March 27, 2018
9.9K
Chronic Coronary Artery Disease.
1Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California (M.M.K.).
Annals of Internal Medicine
|October 13, 2025
Summary
Chronic coronary artery disease (CCAD) is a major cause of death. New medications are now available to help reduce ischemic complications in patients with this condition.
Area of Science:
- Cardiology
- Vascular Biology
- Metabolic Medicine
Background:
- Chronic coronary artery disease (CCAD) is a significant global health burden, primarily caused by myocardial metabolic demand exceeding oxygen supply due to coronary artery atherosclerosis.
- The clinical manifestation of CCAD, typically angina, shows considerable patient-to-patient variability.
- The pathophysiology involves an imbalance between the heart's energy needs and its oxygen delivery, predominantly driven by atherosclerosis.
Purpose of the Study:
- To provide an updated overview of chronic coronary artery disease (CCAD).
- To highlight recent advancements in therapeutic options for managing CCAD.
- To discuss the evolving understanding of CCAD pathobiology and clinical presentation.
Main Methods:
- Literature review of recent studies and clinical trials.
- Analysis of newly approved pharmacological interventions for CCAD.
- Synthesis of current clinical guidelines and expert consensus.
Main Results:
- Several new medications have been approved since 2019 to mitigate ischemic events in CCAD patients.
- Advances in understanding CCAD pathophysiology continue to emerge.
- Recognition of diverse clinical presentations beyond classic angina.
Conclusions:
- CCAD remains a critical area of cardiovascular medicine requiring ongoing research and clinical attention.
- Newly available medications offer improved strategies for managing CCAD and reducing ischemic complications.
- A comprehensive approach considering pathobiology and varied clinical presentations is essential for effective CCAD patient care.
Related Concept Videos
01:30Coronary Artery Disease I: Introduction
878
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
878
01:30Coronary Artery Disease III: Clinical Manifestations
325
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
325
01:26Coronary Artery Disease II: Pathophysiology
367
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
367
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
354
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
354
01:26Coronary Artery Disease IV: Preventive Measures
589
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
589
01:22Chronic Obstructive Pulmonary Disease
2.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.2K